Bibliographic information
GuidelineWHO recommendations on maternal and newborn care for a positive postnatal experience.
Year of Publication2022
Issuing InstitutionWorld Health Organization
Recommendation
New
The use of pharmacological interventions such as subcutaneous oxytocin and proteolytic enzyme therapy for the treatment of breast engorgement in the postpartum period is not recommended.
Not recommended
Certainty of evidence
Very low
Notes and Remarks
Remarks
- In making this recommendation, the Guideline Development Group emphasized breastfeeding counselling and support as the treatment of choice for breast engorgement after childbirth (see Recommendation 8 in this guideline).
- All women should receive continued breastfeeding advice and support and decide on breast engorgement treatment options based on their individual preferences.